Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus documentMarieke Biegstraaten, Carla E. M. Hollak, Reynir Arngrı́msson et al.|Orphanet Journal of Rare Diseases|2015Cited by 345
Multidisciplinary Management of Hunter SyndromeJoseph Muenzer, Ed Wraith, Michael Beck et al.|PEDIATRICS|2009Cited by 193
The definition of neuronopathic Gaucher diseaseRaphael Schiffmann, Ari Zimran, Elena Lukina et al.|Journal of Inherited Metabolic Disease|2020Cited by 102
Current management of children and young people with heterozygous familial hypercholesterolaemia - HEART UK statement of careUma Ramaswami, Andrew A. M. Morris, Steve E. Humphries et al.|Atherosclerosis|2019Cited by 72